Overview
March 2, 2016 - Tutorial (PM)*
March 3-4, 2016 - Conference
*Tutorials require registration and are an additional fee
Now in its 27th year, the DIA Marketing Pharmaceuticals 2016 Planning Team created a program that celebrates the conference components you look forward to each year while INCREASING the number of varied content offerings, INTRODUCING new interactive session formats, and providing MORE structured networking opportunities.
This conference is designed for professionals working through regulatory and compliance challenges in the marketing, advertising, and promotion of pharmaceuticals, veterinary products, biologics, and medical devices.
NEW Conference Features:
- Attend a DIA Advertising and Promotion Working Group (APWG) Meeting – meet members from DIA’s Regulatory Affairs Ad Promo community and learn how to get involved on March 2, 5:15-6:30PM.
- DIA Mobile App – keep connected throughout the conference and engage in session polls
- Round Table Discussion Luncheon – conversations inspired by sessions and led by community leaders on March 4, 11:30AM-1:00PM.
- Poster Presentations – view poster presentations throughout the conference
- More Interactive Sessions – learn from industry experts and from each other through panel and audience discussion
“Why Do I Attend DIA’s Marketing Pharmaceuticals Conference?” Top 5 Responses from Attendee Survey. TO:
- interact with OPDP leadership and personnel
- network with my industry colleagues and meet current and future clients
- participate in a Live information exchange between industry and government on best practice trends and issues
- learn the latest industry best practices and guidelines
- earn ACPE and IACET credits
Featured topics
- FDA updates on recent enforcement actions and guidances
- Litigation
- Compliance updates
- Safety labeling changes: real world execution into packaging, advertising, and promotion
- Engaging payors, nontraditional, and emerging customer markets
- Advocacy groups: when & how should they be engaged?
- How to remain compliant in a global environment
- Scientific exchange
- Social media: using new and emerging technologies compliantly
- Global advertising and promotion processes and standards
Featured
Short Course or Primer
-
Mar 02, 2016
Tutorial: OPDP/APLB 101: A Primer Based on Today’s Changing Environment
Learn more
Who should attend?
Professionals in pharmaceutical, biologics, and medical device companies involved in:
- Regulatory Affairs
- Marketing
- Communications
- Compliance
- Medical Information and Affairs
- Legal
- Senior Management
Learning objectives
At the conclusion of this conference, participants should be able to:
- Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
- Examine the compliance challenges companies face, including how to evaluate challenges, and factors to consider that may impact the development of solutions
- Discuss the best US and global review and approval practices
- Describe promotional and non-promotional tactics trending in the pharmaceutical industry that require thoughtful regulatory review
- Analyze effective digital and social media strategies designed to meet the challenges of ensuring compliance with FDA regulatory requirements
Program Committee
-
Thomas W. Abrams, MBA, RPh • Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Former FDA, United States -
Glenn N. Byrd, MBA • President
GByrd Ad-Promo Solutions, LLC, United States -
Dale Cooke, JD, MA • President
PhillyCooke Consulting , United States -
Mark Gaydos • Vice President & Global Head, Advertising, Promotion & Labeling
Sanofi, United States -
Lynette Hopkinson • Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
Vertex Pharmaceuticals Incorporated, United States -
John T. Murray • President
Grayscale Compliance LLC, United States -
Wayne Pines • President, Health Care
APCO Worldwide Inc., United States -
Lucy Rose, MBA • President
Lucy Rose and Associates, United States -
Kristina Vlaovic, MPH • Vice President, Regulatory, Safety and Pharmacovigilance
HALOZYME Inc., United States
Contact us
Registration Questions?
Send Email
1.888.257.6457 +1.215.442.6100
